SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 23.39 |
| Enterprise Value ($M) | 29.59 |
| Book Value ($M) | -4.97 |
| Book Value / Share | -0.58 |
| Price / Book | -4.70 |
| NCAV ($M) | -15.62 |
| NCAV / Share | -1.81 |
| Price / NCAV | -1.50 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.82 |
| Return on Assets (ROA) | -0.65 |
| Return on Equity (ROE) | -6.82 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.36 |
| Current Ratio | 1.36 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 14.67 |
| Assets | 25.31 |
| Liabilities | 30.29 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.34 |
| Operating Income | -33.09 |
| Net Income | -39.40 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -21.33 |
| Cash from Investing | 6.32 |
| Cash from Financing | -1.53 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.99 | -40.13 | |
| 13G/A | AWM Investment Company, Inc. | 5.70 | -96.06 | |
| 13G/A | Mosca Alison | 19.70 | 94.89 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 10,535 | 54,723 | 19.25 | |
| 25,347 | 105,366 | 24.06 | |
| 18,490 | 53,278 | 34.70 | |
| 25,789 | 167,563 | 15.39 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CING – Cingulate Inc. | CKPT – Checkpoint Therapeutics, Inc. |
| CLDX – Celldex Therapeutics, Inc. | CLRB – Cellectar Biosciences, Inc. |
| CMPX – Compass Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io